4Mar/100
Takeda renames heartburn drug to avoid errors (AP)
AP - Federal regulators said Thursday that Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.